The drug resistance profiling further indicated that high expression of COL4A1, THBS2, and CTNNB1 was associated with reduced sensitivity to a range of chemotherapeutic agents, suggesting that these genes may contribute to an intrinsic or acquired drug-resistant phenotype in STAD. The gene discussed is COL4A1; the disease is gastric adenocarcinoma.